X
 

EdiGene

Genome Editing for A Better Life

EdiGene innovates and applies genome editing technology to developing human therapeutic products. Our therapeutic approach is to treat diseases at the molecular level, making gene therapy safer and more effective. We will explore new strategies in treating diseases with high incidence in China and the world, including cancer, the genetic diseases and the infectious diseases.

learn more
 

EdiGene

Genome Editing for A Better Life

EdiGene integrates genome editing technology and high throughput genetic screening technology to accelerate new drug target discovery and clarify the mode of action of drug candidates, improving the development of novel therapeutic strategies and drugs for precision medicine. We own a series of libraries and sub-libraries, and can generate customized libraries to meet special need for high throughput screens to accelerate drug discovery and clinical trials.

learn more
 

EdiGene

Genome Editing for A Better Life

EdiGene develops and optimizes genome editing technology to produce stable genome edited mammalian cell lines serving a wide-range of R&D activities in areas of basic research, diagnostic and therapeutic development. EdiGene’s patented technology enables effective and efficient gene knockout cell line production. This enables the possibility of a new Quality Control standard “EdiGene KO Validated” for high quality antibodies, which could revolutionize the antibody industry.

learn more
     
left right



EdiGene

EdiGene Inc. is dedicated to the development of genome editing technology for human health. Genome editing technology enables the targeted modification of genetic information in human cells, including gene knockout, knock-in and targeted mutations. We aim at providing the high quality products and services for the patients, the pharmaceutical industry, and the scientific research community with the most advanced genome editing technology.

Learn More

News

BioLegend joins forces with EdiGene to provide Knockout (KO) validated antibodies

BEIJING, June 28, 2017. EdiGene Inc. announced today that BioLegend, a world renowned manufacturer of biomedical research reagents, is teaming up with EdiGene, a genome editing company...

EdiGene Inc. and GeneTex Inc. Signed License and Supply Agreement

Antibodies are essential tools for both basic and clinical research. However, there has been growing distrust of commercially available antibodies with regard to specificity and performance variability.

EdiGene Attended the P4 China-International Precision Medicine Convention

From December 16th to December18th 2016, P4 China-International Precision Medicine Convention was held in Beijing successfully. There were 60 regulators, leading experts and well-known enterprise...

EdiGene and OriGene Technologies Announce Joint Development...

November 7, 2016 –EdiGene announced that it has entered into a multi-year strategic agreement with OriGene technologies to develop genome wide knockout cells from commonly used laboratory cell lines...

EdiGene   at   the   World   Life    Science   Conference   2016

From November 1st to November 3rd, 2016, the World Life Science Conference (WLSC) was held in the China National Convention Center (CNCC) in Beijing, China. This conference was an academic meeting with ...

EdiGene was invited to attend the international conference on antibody...

September 25-27, at Asilomar US A,the seminar about antibody validation was held by GBSI (Global Biological Standards Institute), which aim to develop a scoring system and guidelines for antibody validation...

EdiGene attended the 2nd international forum of young life scientists BDA...

On September24th-25th, the 2nd international forum of young life scientists BDA and Bio therapy summit was held in Beijing successfully.As a leading genome editing technology enterprise,EdiGene was invited...

EdiGene Was Awarded the "Star of Haichuang" Prize by the Zhongguancun ...

On January 22, 2016, the "2016 Chinese New Year Celebration of Haidian Pioneer Park Entrepreneurs’ Club” sponsored by Beijing Zhongguancun Haidian Pioneer Park was held at the Zhongguancun Venture Building.

EdiGene Participates in an Investor Meeting in Zhuangguancun...

On May 18, 2016, company promotional event of Zhongguancun Science Park was hosted successfully in the Pioneer Park (Haidian), which was sponsored by the Management Committee of Zhongguancun Science ...

EdiGene Inc. Awarded the “Zhuangguancun High-tech Enterprise”

Initiated by the US president Obama in his State of the Union speech, the "Precision Medicine" became the popular topic and activated the medicine healthcare market. China proposed our own program...

Contact Us

Tel:+86-010-8073 3899-802            Address:Changping District No. 22 Science Park

Feedback